FI112661B - Antiproliferatiivisina aineina ja Garft-inhibiitteinä käyttökelpoisia yhdisteitä - Google Patents

Antiproliferatiivisina aineina ja Garft-inhibiitteinä käyttökelpoisia yhdisteitä Download PDF

Info

Publication number
FI112661B
FI112661B FI970318A FI970318A FI112661B FI 112661 B FI112661 B FI 112661B FI 970318 A FI970318 A FI 970318A FI 970318 A FI970318 A FI 970318A FI 112661 B FI112661 B FI 112661B
Authority
FI
Finland
Prior art keywords
formula
compound
compounds
defined above
mmol
Prior art date
Application number
FI970318A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970318A0 (fi
FI970318A (fi
Inventor
Michael D Varney
Cynthia L Palmer
William H Romines
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of FI970318A0 publication Critical patent/FI970318A0/fi
Publication of FI970318A publication Critical patent/FI970318A/fi
Application granted granted Critical
Publication of FI112661B publication Critical patent/FI112661B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
    • C07D517/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI970318A 1994-07-28 1997-01-24 Antiproliferatiivisina aineina ja Garft-inhibiitteinä käyttökelpoisia yhdisteitä FI112661B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US1994/008522 WO1996003407A1 (en) 1994-07-28 1994-07-28 Compounds useful as antiproliferative agents and garft inhibitors
SG9608313 1994-07-28
SG1996008313A SG44827A1 (en) 1994-07-28 1994-07-28 Compounds useful as antiproliferative agents and garft inhibitors
US9408522 1994-07-28

Publications (3)

Publication Number Publication Date
FI970318A0 FI970318A0 (fi) 1997-01-24
FI970318A FI970318A (fi) 1997-03-05
FI112661B true FI112661B (fi) 2003-12-31

Family

ID=26665124

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970318A FI112661B (fi) 1994-07-28 1997-01-24 Antiproliferatiivisina aineina ja Garft-inhibiitteinä käyttökelpoisia yhdisteitä

Country Status (13)

Country Link
EP (1) EP0783507B1 (de)
JP (1) JP3473956B2 (de)
AT (1) ATE242253T1 (de)
AU (1) AU698868B2 (de)
DE (1) DE69432801T2 (de)
DK (1) DK0783507T3 (de)
ES (1) ES2201079T3 (de)
FI (1) FI112661B (de)
NO (1) NO308997B1 (de)
NZ (1) NZ271766A (de)
RU (1) RU2136686C1 (de)
SG (1) SG44827A1 (de)
WO (1) WO1996003407A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831100A (en) * 1995-06-07 1998-11-03 Agouron Pharmaceuticals, Inc. Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates
US20040043959A1 (en) * 2002-03-04 2004-03-04 Bloom Laura A. Combination therapies for treating methylthioadenosine phosphorylase deficient cells
WO2004113328A1 (en) * 2003-06-25 2004-12-29 Pfizer Inc. Convergent asymmetric synthesis route to produce a key intermediate towards the synthesis of a garft inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123550A (en) * 1977-10-31 1978-10-31 Syntex (U.S.A.) Inc. Bicyclo[3.1.0]hexylethylaminocarbonyl-substituted heteroaryl cardiovascular agents
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
EP0438261A3 (en) * 1990-01-16 1992-02-26 Takeda Chemical Industries, Ltd. Condensed heterocyclic glutamic acid derivatives, their production and use
CA2151588C (en) * 1992-12-16 2002-03-19 Michael D. Varney Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone

Also Published As

Publication number Publication date
AU7552094A (en) 1996-02-22
NZ271766A (en) 1999-01-28
EP0783507B1 (de) 2003-06-04
DE69432801D1 (de) 2003-07-10
FI970318A0 (fi) 1997-01-24
NO308997B1 (no) 2000-11-27
WO1996003407A1 (en) 1996-02-08
SG44827A1 (en) 1997-12-19
ES2201079T3 (es) 2004-03-16
AU698868B2 (en) 1998-11-12
NO970350L (no) 1997-03-12
ATE242253T1 (de) 2003-06-15
FI970318A (fi) 1997-03-05
JPH10504541A (ja) 1998-05-06
DE69432801T2 (de) 2003-12-04
RU2136686C1 (ru) 1999-09-10
JP3473956B2 (ja) 2003-12-08
NO970350D0 (no) 1997-01-27
EP0783507A1 (de) 1997-07-16
DK0783507T3 (da) 2003-09-15

Similar Documents

Publication Publication Date Title
US5608082A (en) Compounds useful as antiproliferative agents and GARFT inhibitors
AU715751B2 (en) New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them
US5625061A (en) Compounds useful in preparing antiproliferative agents and garft inhibitors
FI112661B (fi) Antiproliferatiivisina aineina ja Garft-inhibiitteinä käyttökelpoisia yhdisteitä
US4891427A (en) Tricyclic cepham compounds
JPS6383082A (ja) テトラヒドロフランカルボン酸誘導体の製造法
US4371532A (en) Malonamidooxadethiacephem compounds
GB2154585A (en) Prodrugs of antiinflammatory oxicams
US4851422A (en) Antibiotic 2-(3-oxo-2-isoxazolidinyl)-5-oxo-2-tetrahydrofuran-carboxylates
JPS59152385A (ja) ヒドロキサム酸系セフアロスポリン誘導体
KR930005174B1 (ko) 항생물질 유도체의 제조방법
CA2195417A1 (en) Compounds useful as antiproliferative agents and garft inhibitors
JPS62215585A (ja) シクロカナリン誘導体およびその製造法
IE870861L (en) Azepine and thiazepine derivatives
KR930001405B1 (ko) 2-(4-치환아미노-3-옥소-이속사졸리디닐)-5-옥소-2-테트라히드로푸란카르복실산 유도체의 제조방법
KR100382778B1 (ko) 항증식제및garft억제제로유용한화합물
JPS62215583A (ja) ピラゾリジノン誘導体およびその製造法
PL95747B1 (pl) Sposob wytwarzania nowych pochodnych penamu
JPS6013787A (ja) 新規なアゼチジノン誘導体およびその塩類
JPH05310688A (ja) ビニルチオ酢酸誘導体
HU197742B (hu) Eljárás izoxazolidinil-tetrahidrofurán-kárbonsav antibiotikum-származékok, és hatóanyagként e vegyületeket tartalmazó gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
MA Patent expired